These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression. Phadke MS; Sini P; Smalley KS Mol Cancer Ther; 2015 Jun; 14(6):1354-64. PubMed ID: 25873592 [TBL] [Abstract][Full Text] [Related]
27. ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma. Ojha R; Leli NM; Onorati A; Piao S; Verginadis II; Tameire F; Rebecca VW; Chude CI; Murugan S; Fennelly C; Noguera-Ortega E; Chu CT; Liu S; Xu X; Krepler C; Xiao M; Xu W; Wei Z; Frederick DT; Boland G; Mitchell TC; Karakousis GC; Schuchter LM; Flaherty KT; Zhang G; Herlyn M; Koumenis C; Amaravadi RK Cancer Discov; 2019 Mar; 9(3):396-415. PubMed ID: 30563872 [TBL] [Abstract][Full Text] [Related]
28. BIF-1 inhibits both mitochondrial and glycolytic ATP production: its downregulation promotes melanoma growth. Frangež Ž; Fernández-Marrero Y; Stojkov D; Seyed Jafari SM; Hunger RE; Djonov V; Riether C; Simon HU Oncogene; 2020 Jun; 39(26):4944-4955. PubMed ID: 32493957 [TBL] [Abstract][Full Text] [Related]
29. Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. Li X; Qian X; Lu Z Autophagy; 2017 Oct; 13(10):1790-1791. PubMed ID: 28820290 [TBL] [Abstract][Full Text] [Related]
30. Vemurafenib resistance reprograms melanoma cells towards glutamine dependence. Hernandez-Davies JE; Tran TQ; Reid MA; Rosales KR; Lowman XH; Pan M; Moriceau G; Yang Y; Wu J; Lo RS; Kong M J Transl Med; 2015 Jul; 13():210. PubMed ID: 26139106 [TBL] [Abstract][Full Text] [Related]
31. Simulation of the metabolism of absorbed energy-yielding nutrients in young sheep: efficiency of utilization of acetate. Black JL; Gill M; Beever DE; Thornley JH; Oldham JD J Nutr; 1987 Jan; 117(1):105-15. PubMed ID: 3819858 [TBL] [Abstract][Full Text] [Related]
32. Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation. Lee JS; Lee H; Lee S; Kang JH; Lee SH; Kim SG; Cho ES; Kim NH; Yook JI; Kim SY EBioMedicine; 2019 Feb; 40():184-197. PubMed ID: 30686754 [TBL] [Abstract][Full Text] [Related]